Statement by CleanSlate Centers on Obama Administration’s Actions to Escalate Fight Against Prescription Opioid Abuse and Heroin Epidemic

Share Article

Massachusetts, Pennsylvania, Indiana-based CleanSlate Centers react to Obama Administration’s announcement

CSC Logo

The Administration’s recognition of the critical importance of addressing the epidemic through expanding access to life saving medical care may well prove to be a turning point in our fight against this disease.

Regarding today’s announcement from the Obama Administration, Amanda Wilson, MD, President and CEO, Clean Slate Centers stated:

“The opioid and heroin epidemic is a national crisis that requires all of our resources including those of the federal government. By working together with leaders from the national, state, and local levels, we will positively impact this epidemic and provide quality care and recovery for those struggling with addiction.”

Kelly J. Clark, MD, MBA, DFAPA, DFASAM, CMO of CleanSlate Centers and President Elect of the American Society of Addiction Medicine added:

"CleanSlate Centers has been a pioneer in treating addiction using a combined biological, psychological, and social approach. This evidenced-based care has proven effective in helping those in need to succeed in managing this challenging disorder. The Administration’s recognition of the critical importance of addressing the epidemic through expanding access to life saving medical care may well prove to be a turning point in our fight against this disease."

About CleanSlate Centers

CleanSlate Centers was founded in 2009 in response to the growing opioid epidemic facing the country. A network of outpatient addiction treatment centers, CleanSlate provides compassionate, effective, medication assisted treatment and related therapies for patients who have addiction and associated disorders using the highest quality, evidence-based practices.

In recognition of their innovation and effectiveness, CleanSlate’s treatment programs received the inaugural 2008 Science and Service Award for Office-based Opioid Treatment by the federal Substance Abuse and Mental Health Service Administration (SAMHSA).

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Cooney
WilMark Group
+1 4079216932
Email >